SCHEMBL1123593

SCHEMBL1123593

CC(C)(C)c1ccc(CN(CCC(=O)O)C(=O)c2cccc(OCCN(Cc3ccccc3)Cc3ccccc3)c2)cc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NR4A1 P22736 1/20 0.48
NR4A2 P43354 1/20 0.48
NR4A3 Q92570 1/20 0.48
F10 P00742 1/20 0.47
PPARG P37231 2/20 0.46
HDAC1 Q13547 3/20 0.44
HDAC6 Q9UBN7 3/20 0.44
LPAR1 Q92633 2/20 0.44
MAPT P10636 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
KDM4E B2RXH2 1/20 0.43
ALDH1A1 P00352 1/20 0.43
KMT2A Q03164 1/20 0.43
NR1H4 Q96RI1 1/20 0.43
PPARD Q03181 1/20 0.43
NPC1 O15118 1/20 0.42
POLB P06746 1/20 0.42
CASP3 P42574 1/20 0.42
RAB9A P51151 1/20 0.42
SENP7 Q9BQF6 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1122983 0.94 NR4A1 (0.46) NR4A1NR4A2NR4A3F10PPARG
SCHEMBL1122783 0.91 NR4A1 (0.49) NR4A1NR4A2NR4A3F10PPARG
SCHEMBL1123395 0.88 F10 (0.51) NR4A2F10PPARGHDAC1HDAC6
SCHEMBL1123247 0.87 SLC2A1 (0.47) F10PPARGHDAC1HDAC6LPAR1
SCHEMBL1123394 0.87 KMT2A (0.52) NR4A2F10PPARGKMT2A
SCHEMBL1122385 0.87 PPARG (0.47) F10PPARGHDAC1HDAC6LPAR1
SCHEMBL1123052 0.85 NR4A1 (0.45) NR4A1NR4A2NR4A3F10LPAR1
SCHEMBL1123557 0.85 PTGES (0.52) NR4A2F10PPARGKMT2A
SCHEMBL1122912 0.85 LPAR1 (0.49) F10PPARGLPAR1KDM4EALDH1A1
SCHEMBL1123465 0.82 SLC2A1 (0.51) F10PPARGHDAC1HDAC6LPAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1644321-B1 NEW BENZAMIDES AS PPATY MODULATORS S A L V A T LAB SA (ES) 2011-02-09 EP disclosed
US-20060160894-A1 Benzamides as ppar modulators LABORATORIOS S.A.L.V.A.T.,S.A. (ES) 2006-07-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060160894-A1 Benzamides as ppar modulators PPARD, PPARA, PPARG NR4A1 46/4885NR4A2 66/4885NR4A3 88/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.